Ph.D., University of Manchester, U.K., 1976
Stuart Lindsay, Ph.D., specializes in biophysics at the molecular level and scanning probe microscopy. Much of his work is aimed at speedier diagnosis and an understanding of the molecular basis of disease. He holds 29 US patents and is a technology advisor for the Atomic Force Microscope Division of Agilent Technologies. Agilent has acquired Molecular Imaging Corporation, which he co-founded in 1993.
Dr. Lindsay's lab conducts innovative research in biological physics, molecular electronics, solar energy and condensed matter physics. The Lindsay Lab researchers are interested in how genes work, and study the way in which proteins change DNA structure to switch genes on and off. They are also interested in the chemistry and physics of the liquid-solid interface, and are trying to understand electrochemical and charge transfer processes at the single-molecule level. One project that Dr. Lindsay is pursuing is a new method of DNA sequencing to allow much faster and cheaper sequencing of individual human genomes. His radical approach involves electron tunneling through electrodes funtionalized with molecules that recognize the DNA bases.
His 29 patents cover mostly technology for atomic force microscopy and new devices based on molecular electronics. After receiving his PhD in Physics from the University of Manchester, Dr. Lindsay spent two years as a consultant at Philips Industries in London before joining the faculty at ASU. He has been at ASU for 30 years. His body of published work comprises over 200 articles in peer-reviewed journals. He is the author of the first comprehensive text for nanoscience, "Introduction to Nanoscience" (OUP, 2009). Dr. Lindsay sits on the editorial boards of Biophysical Journal and AIP Press International Series in Basic and Applied Biological Physics. He also holds the position of Associate Editor for Probe Microscopy at Ultramicroscopy. He is a fellow of the American Association for the Advancement of Science and the American Physical Society.
Stuart Lindsay is Director of the Center for Single Molecule Biophysics in the Biodesign Institute at Arizona State University, a Regentâs Professor and Nadine and Edward Carson professor of physics and chemistry. He received his B.Sc. and Ph.D. degrees in physics from the University of Manchester, UK. He holds 34 US patents and was co-founder of Molecular Imaging (now part of Agilent Technologies) and more recently, Recognition AnalytiX. He has published over 200 research papers (h=70) and wrote the standard text in the field ( Introduction to Nanoscience , Oxford University Press). He is a fellow of the National Academy of Inventors, the American Physical Society, the American Association for the Advancement of Science and the Institute of Physics.
Regents Professor, Department of Physics and Department of Chemistry and Biochemistry, College of Liberal Arts and Sciences.